Alan Shuldiner
Affiliations: | Molecular Medicine | University of Maryland School of Medicine, Baltimore, MD, United States |
Area:
Molecular Biology, Medicine and Surgery, GeneticsGoogle:
"Alan Shuldiner"Children
Sign in to add trainee| Jessica Albert | grad student | 2012 | University of Maryland Medical School |
| Alexis Gorden | grad student | 2014 | University of Maryland Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Böger CA, Gorski M, McMahon GM, et al. (2017) NFAT5 and SLC4A10 Loci Associate with Plasma Osmolality. Journal of the American Society of Nephrology : Jasn |
| O'Hare EA, Yang R, Yerges-Armstrong L, et al. (2016) TM6SF2 rs58542926 impacts lipid processing in liver and small intestine. Hepatology (Baltimore, Md.) |
| Albert JS, Yerges-Armstrong LM, Horenstein RB, et al. (2014) Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes. The New England Journal of Medicine. 370: 2307-15 |
| Gorden A, Yang R, Yerges-Armstrong LM, et al. (2013) Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity. Human Heredity. 75: 34-43 |
| Gordon D, Montague K, Louis TA, et al. (2013) Front and Back Matter Human Heredity. 75 |
| Delahanty LM, Pan Q, Jablonski KA, et al. (2012) Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program. Diabetes Care. 35: 363-6 |
| Howell CD, Gorden A, Ryan KA, et al. (2012) Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1. Journal of Hepatology. 56: 557-63 |
| Scott SA, Sangkuhl K, Gardner EE, et al. (2011) Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy. Clinical Pharmacology and Therapeutics. 90: 328-32 |
| Dehghan A, Dupuis J, Barbalic M, et al. (2011) Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation. 123: 731-8 |
| Beitelshees A, Horenstein R, Vesely, et al. (2011) Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions Clinical Pharmacology & Therapeutics. 89: 455-459 |